ImmunityBio Files 8-K: Material Agreement, Financials
Ticker: IBRX · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1326110
| Field | Detail |
|---|---|
| Company | Immunitybio, Inc. (IBRX) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-condition, corporate-history
TL;DR
ImmunityBio dropped an 8-K on July 24th detailing a new material agreement and financial updates.
AI Summary
ImmunityBio, Inc. announced on July 24, 2025, that it entered into a material definitive agreement. The company also disclosed its results of operations and financial condition, along with other events and financial statements and exhibits. This filing follows a period of significant corporate changes, including previous name changes from NantKwest, Inc., Conkwest, Inc., and ZelleRx Corp.
Why It Matters
This 8-K filing provides crucial updates on ImmunityBio's financial health and strategic agreements, which could impact investor confidence and future stock performance.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to significant stock price volatility.
Key Players & Entities
- ImmunityBio, Inc. (company) — Registrant
- July 24, 2025 (date) — Date of earliest event reported
- NantKwest, Inc. (company) — Former company name
- Conkwest, Inc. (company) — Former company name
- ZelleRx Corp (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by ImmunityBio, Inc.?
The filing indicates that ImmunityBio, Inc. entered into a material definitive agreement on July 24, 2025, but the specific details of this agreement are not provided in the provided text.
What financial information is being disclosed in this 8-K filing?
The filing states that it includes 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific financial figures are not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on July 24, 2025.
What were ImmunityBio, Inc.'s previous names?
ImmunityBio, Inc. was formerly known as NantKwest, Inc., Conkwest, Inc., and ZelleRx Corp.
In which state is ImmunityBio, Inc. incorporated?
ImmunityBio, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding ImmunityBio, Inc. (IBRX).